Atomo Diagnostics Pty Limited:企業の製品パイプライン分析2018

◆英語タイトル:Atomo Diagnostics Pty Limited - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12212
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atomo Diagnostics Pty Ltd (Atomo Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes in-vitro diagnostic products. The company offers AtomoRapid HIV, a human immunodeficiency virus (HIV) rapid test kit; and AtomoRapid malaria, a kit to test malaria infections. Its products are used for self-test consumer applications for detecting infectious diseases, measuring markers and hormone levels, and screening for chronic conditions. The company develops its products using OEM device platform. It also offers custom devices. Atomo Diagnostics is headquartered in Sydney, New South Wales, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Atomo Diagnostics Pty Limited
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Atomo Diagnostics Pty Limited Company Overview 4
Atomo Diagnostics Pty Limited Company Snapshot 4
Atomo Diagnostics Pty Limited Pipeline Products and Ongoing Clinical Trials Overview 4
Atomo Diagnostics Pty Limited – Pipeline Analysis Overview 7
Atomo Diagnostics Pty Limited – Key Facts 7
Atomo Diagnostics Pty Limited – Major Products and Services 8
Atomo Diagnostics Pty Limited Pipeline Products by Development Stage 9
Atomo Diagnostics Pty Limited Pipeline Products Overview 12
Atomo HIV Self Test 12
Atomo HIV Self Test Product Overview 12
AtomoRapid – Allergy 13
AtomoRapid – Allergy Product Overview 13
AtomoRapid – Celiac Disease 14
AtomoRapid – Celiac Disease Product Overview 14
AtomoRapid – Chikungunya 15
AtomoRapid – Chikungunya Product Overview 15
AtomoRapid – Coagulation Monitoring 16
AtomoRapid – Coagulation Monitoring Product Overview 16
AtomoRapid – Dengue 17
AtomoRapid – Dengue Product Overview 17
AtomoRapid – Hepatitis C 18
AtomoRapid – Hepatitis C Product Overview 18
AtomoRapid – Malaria 19
AtomoRapid – Malaria Product Overview 19
Atomo Diagnostics Pty Limited – Key Competitors 20
Atomo Diagnostics Pty Limited – Key Employees 21
Atomo Diagnostics Pty Limited – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Atomo Diagnostics Pty Limited, Recent Developments 23
Jan 23, 2018: Atomo Diagnostics and Access Bio partner to expand access to best-in-class HIV rapid testing in global markets 23
Dec 07, 2017: Expert Review Panel for Diagnostics Approves Atomo HIV Self Test for Procurement by Unitaid and the Global Fund 23
Oct 10, 2017: CE Marking for world’s only integrated HIV Self-Test from Atomo Diagnostics gives access to safe, accurate and reliable self-testing 24
May 30, 2017: Atomo Diagnostics’ HIV Self Test receives approval from Kenya Ministry of Health 25
Jun 02, 2016: Atomo Diagnostics: Innovative New Rapid Blood Test to Tackle Tropical Diseases 25
Jun 02, 2016: Atomo Diagnostics: Innovative New Rapid Blood Test to Tackle Tropical Diseases 26
May 05, 2016: Atomo Diagnostics secures $6M investment to scale up activities related to its rapid diagnostics test platform, AtomoRapid 26
Jun 11, 2014: Atomo Diagnostics’ AtomoRapid Blood Test Device Scoops Best in Show at the Medical Design Excellence Awards 2014 26
Apr 08, 2014: Groundbreaking AtomoRapid HIV selected as Finalist in 2014 Medical Design Excellence Awards 27
Appendix 28
Methodology 28
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Atomo Diagnostics Pty Limited Pipeline Products and Ongoing Clinical Trials Overview 4
Atomo Diagnostics Pty Limited Pipeline Products by Equipment Type 5
Atomo Diagnostics Pty Limited Pipeline Products by Indication 6
Atomo Diagnostics Pty Limited, Key Facts 7
Atomo Diagnostics Pty Limited, Major Products and Services 8
Atomo Diagnostics Pty Limited Number of Pipeline Products by Development Stage 9
Atomo Diagnostics Pty Limited Pipeline Products Summary by Development Stage 10
Atomo HIV Self Test - Product Status 12
Atomo HIV Self Test - Product Description 12
AtomoRapid - Allergy - Product Status 13
AtomoRapid - Allergy - Product Description 13
AtomoRapid - Celiac Disease - Product Status 14
AtomoRapid - Celiac Disease - Product Description 14
AtomoRapid - Chikungunya - Product Status 15
AtomoRapid - Chikungunya - Product Description 15
AtomoRapid - Coagulation Monitoring - Product Status 16
AtomoRapid - Coagulation Monitoring - Product Description 16
AtomoRapid - Dengue - Product Status 17
AtomoRapid - Dengue - Product Description 17
AtomoRapid - Hepatitis C - Product Status 18
AtomoRapid - Hepatitis C - Product Description 18
AtomoRapid - Malaria - Product Status 19
AtomoRapid - Malaria - Product Description 19
Atomo Diagnostics Pty Ltd, Key Employees 21
Glossary 30

List of Figures
Atomo Diagnostics Pty Limited Pipeline Products by Equipment Type 5
Atomo Diagnostics Pty Limited Pipeline Products by Development Stage 9

★海外企業調査レポート[Atomo Diagnostics Pty Limited:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sanchez Energy Corp (SN):企業の財務・戦略的SWOT分析
    Summary Sanchez Energy Corp (Sanchez) is an independent exploration and production company that acquires and develops unconventional oil and natural gas resources. It operates in the horizontal development of resources from the Eagle Ford Shale in South Texas. The company also holds an undeveloped a …
  • ActiveCare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …
  • Prudential Plc:戦略・SWOT・企業財務分析
    Prudential Plc - Strategy, SWOT and Corporate Finance Report Summary Prudential Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務分析
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Photocure ASA (PHO):企業の財務・戦略的SWOT分析
    Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Inhalation Sciences Sweden AB-医療機器分野:企業M&A・提携分析
    Summary Inhalation Sciences Sweden AB (ISAB) develops and sells innovative laboratory equipment for inhalation research and provides drug development services. The company's product portfolio includes PreciseInhale and LaminarPace systems. It sells tools and services which accelerates the drug disco …
  • United Spirits Ltd:戦略・SWOT・企業財務分析
    United Spirits Ltd - Strategy, SWOT and Corporate Finance Report Summary United Spirits Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • T-System Inc-医療機器分野:企業M&A・提携分析
    Summary T-System Inc (T-System) is a healthcare service provider that offers clinical, financial, operational, and regulatory solutions. The company offers documentation solutions, which include EV, an emergency department information system; EV for physicians, a solution with ER-specific clinical c …
  • Laboratoires Thea SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Thea SA (Thea) is an independent pharmaceutical company that researches, develops, manufactures, and commercializes a range of eye care products. The company’s products find application in the diagnosis, surgery and treatment of ophthalmic diseases such as dry eye, allergies, gl …
  • Adtran Inc (ADTN):企業の財務・戦略的SWOT分析
    Adtran Inc (ADTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Clevexel Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Clevexel Pharma SAS (Clevexel) is a pharmaceutical company that develops drugs for the treatment of central nervous system diseases. The company’s pipeline product candidate includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease pat …
  • AGILeBiotics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary AGILeBiotics BV (AGILeBiotics) is a pharmaceutical company that focus on the discovery and development of new antibiotics to treat multi-drug resistant infections. The company’s patented synthetic method technology OxaSelect transforms the currently available antibiotics, which became less e …
  • Neuralstem Inc (CUR)-医療機器分野:企業M&A・提携分析
    Summary Neuralstem Inc (Neuralstem) is a developer of medicines for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer’s disease, traumatic brain injury, peripheral nerve injury, diabetic neur …
  • AB Science SA (AB):製薬・医療:M&Aディール及び事業提携情報
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • DTEK Energy BV:企業の戦略的SWOT分析
    DTEK Energy BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Canada Post Corporation:企業の戦略・SWOT・財務情報
    Canada Post Corporation - Strategy, SWOT and Corporate Finance Report Summary Canada Post Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • CDW Corporation:企業の戦略・SWOT・財務情報
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • United Microelectronics Corporation (2303):企業の財務・戦略的SWOT分析
    United Microelectronics Corporation (2303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • F1 Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary F1 Oncology Inc (F1 Oncology) is a developer of adoptive cellular therapy candidates. The company develops CAB technology to mitigate the on-target, off-tumor toxicity of Chimeric Antigen Receptor (CAR) T cell therapy. It is developing CAB technology. The company’s drugs are used in rewiring …
  • The Hachijuni Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Hachijuni Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Hachijuni Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆